US · NNOX
Nano-X Imaging Ltd.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Neve Ilan 9085000
- Website
- nanox.vision
Price · as of 2024-12-31
$1.73
Market cap 151.12M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $25.84 | +1,393.64% |
| Intrinsic Value(DCF) | $2.42 | +39.88% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $43.97 | ||||
| 2021 | $9.09 | ||||
| 2022 | $6.58 | $69.60 | $0.00 | $0.00 | $0.00 |
| 2023 | $10.21 | $26.69 | $0.35 | $0.00 | $0.00 |
| 2024 | $6.04 | $25.84 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Nano-X Imaging Ltd.'s (NNOX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $25.84
- Current price
- $1.73
- AI upside
- +1,393.64%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.42
+39.88% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NNOX | Nano-X Imaging Ltd. | $1.73 | 151.12M | +1,394% | +40% | — | — | -6.62 | 1.87 | 31.38 | -6.41 | — | 2.97 | -94.03% | -502.93% | -474.31% | -27.83% | -46.04% | -24.97% | 0.04 | — | 5.63 | 5.37 | 0.71 | -1574.00% | 1391.00% | -1813.00% | -11.12% | -2.62 | -32.15% | 0.00% | 0.00% | 0.00% | -5.08 | -7.32 | 25.55 | 7.21 |
| HCAT | Health Catalyst, Inc. | $1.62 | 114.58M | +1,831% | +136% | — | — | -3.71 | 0.71 | 0.84 | -25.20 | — | 13.31 | 45.92% | -22.77% | -22.67% | -18.99% | -20.72% | -8.91% | 1.10 | -4.09 | 1.43 | 1.38 | -14.33 | -4498.00% | 360.00% | -9612.00% | -0.71% | 0.04 | -0.55% | 0.00% | 0.00% | 0.00% | -3.85 | -145.98 | 0.88 | -1.34 |
| HSDT | Solana Company | $1.87 | 75.36M | +7,559% | +13,131% | — | +2,272% | -77.89 | 863.60 | 1758.75 | -66.18 | — | 863.60 | -11.92% | -2673.65% | -2258.08% | -688.88% | 995.92% | -209.04% | 0.01 | -817.82 | 1.58 | 0.80 | 0.08 | -4052.00% | -1925.00% | 575.00% | -1.21% | -5.10 | 791.26% | 0.00% | 0.00% | 0.00% | -65.70 | -82.70 | 1756.68 | 140.75 |
| INGN | Inogen, Inc. | $6.10 | 165.61M | +2,817% | -47% | -59% | — | -7.38 | 0.87 | 0.48 | -24.21 | — | 1.11 | 47.58% | -8.66% | -6.52% | -12.43% | -34.66% | -7.65% | 0.09 | — | 3.12 | 2.49 | 31.71 | -4408.00% | 386.00% | 9321.00% | -12.86% | -0.18 | -25.47% | 0.00% | 0.00% | 0.00% | -2.18 | -3.05 | 0.19 | 1.50 |
| MXCT | MaxCyte, Inc. | $0.81 | 86.54M | +3,073% | +164% | -99% | — | -8.96 | 1.78 | 9.53 | -4.99 | -165.84 | 1.78 | 81.62% | -132.54% | -106.29% | -18.73% | -67.18% | -16.17% | 0.09 | — | 10.88 | 10.09 | 0.21 | 541.00% | -644.00% | 1526.00% | -7.95% | -1.75 | -38.39% | 0.00% | 0.00% | 0.00% | -4.52 | -7.91 | 6.00 | 5.62 |
| OM | Outset Medical, Inc. | $3.49 | 63.91M | +1,299% | -32% | — | — | — | 0.43 | 0.45 | 0.16 | — | 0.43 | 39.13% | -55.84% | -68.34% | 0.00% | -100.69% | 0.00% | 0.82 | -4.78 | 6.67 | 5.24 | -1.11 | -8547.00% | 509.00% | -5980.00% | -86.78% | -1.23 | -71.12% | 0.00% | — | 15.34% | 0.15 | 0.21 | -0.08 | -5.38 |
| PROF | Profound Medical Corp. | $7.61 | 229.84M | +279% | -61% | — | — | -6.11 | 2.81 | 16.71 | -4.69 | — | 2.82 | 65.89% | -309.57% | -260.45% | -60.70% | -267.75% | -48.72% | 0.08 | — | 10.52 | 9.44 | 1.95 | -2074.00% | 4123.00% | 373.00% | -13.80% | -3.57 | -199.52% | 0.00% | 0.00% | 18.51% | -3.82 | -5.12 | 11.81 | 5.24 |
| QTRX | Quanterix Corporation | $6.55 | 305.96M | +237% | -22% | -45% | — | -7.37 | 0.86 | 2.10 | -0.73 | -45.26 | 0.87 | 59.89% | -38.85% | -28.45% | -11.33% | -70.92% | -9.23% | 0.11 | — | 8.66 | 7.65 | 0.44 | 1628.00% | 1180.00% | 6982.00% | -13.57% | -0.84 | -51.94% | 0.00% | 0.00% | 0.00% | -0.61 | -0.83 | 0.24 | 1.46 |
| SNWV | SANUWAVE Health, Inc. | $24.33 | 208.62M | +2,106% | +2,696% | — | — | -4.13 | -10.18 | 3.97 | -8.74 | — | -5.46 | 75.23% | 16.60% | -96.13% | 112.25% | -90.44% | -119.43% | -2.00 | 0.40 | 0.43 | 0.32 | -0.92 | -4233.00% | 5999.00% | -14330.00% | 1.52% | 0.06 | -32.81% | 0.00% | 0.00% | 10.35% | 26.71 | 73.63 | 4.43 | -9.15 |
| TLSI | TriSalus Life Sciences, I… | $5.06 | 167.17M | +547% | +1,763% | — | — | -4.73 | -5.49 | 4.83 | -4.35 | — | -5.49 | 86.06% | -122.88% | -112.92% | 113.47% | 150.57% | -123.72% | -0.91 | -11.70 | 2.02 | 1.33 | -0.42 | -4395.00% | 5899.00% | -1950.00% | -29.00% | -3.99 | 171.48% | 0.00% | 0.00% | 0.00% | -4.35 | -3.82 | 5.34 | -17.85 |
About Nano-X Imaging Ltd.
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
- CEO
- Erez I. Meltzer
- Employees
- 165
- Beta
- 1.35
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.42 ÷ $1.73) − 1 = +39.88% (DCF, example).